A quick google tells me that (a) this is for lung cancer and (b) doesn't appear to be a radiation therapy.
Telix is addressing lung cancer- along with many other cancers- as part of its STARBURST trial but it's not a specific target of a major program right now was far as I am aware.
The company that might be pleased at someone else's failure is RAD, who have a Phase 1 trial for lung cancer happening in Adelaide. I only know a tiny bit about RAD so cannot say anything useful about that company.
General comments about how the trial failure affects the landscape etc etc no idea sorry.
However, the reason I was looking up Adelaide clinical trial data was because I was trying to find out more about Telix's APOMAB collaboration/ trial, which I haven't heard anything about recently. A general question for everyone: Have I missed something?
Understanding Telix, page-1445
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.90 |
Change
-0.010(0.04%) |
Mkt cap ! $7.664B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $23.19 | $22.40 | $16.31M | 715.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3391 | $22.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.93 | 2866 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |